Annual report [Section 13 and 15(d), not S-K Item 405]

Cash, Cash Equivalents, Restricted Cash and Marketable Debt Securities (Tables)

v3.25.1
Cash, Cash Equivalents, Restricted Cash and Marketable Debt Securities (Tables)
12 Months Ended
Dec. 31, 2024
Cash and Cash Equivalents [Abstract]  
Schedule of Cash, Cash Equivalents and Restricted Cash

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported in the Consolidated Balance Sheets to the total of the amounts in the Consolidated Statements of Cash Flows as of December 31, 2024, December 31, 2023 and December 31, 2022:

 

   

December 31,

2024

   

December 31,

2023

   

December 31,

2022

 
Cash and cash equivalents   $ 7,284     $ 4,787     $ 6,830  
Restricted cash included in current/non-current assets     250       250       250  
Cash, cash equivalents and restricted cash in the statement of cash flows   $ 7,534     $ 5,037     $ 7,080  
Schedule of Marketable Debt Securities

The Company did not own any marketable debt securities at December 31, 2024. The following tables summarize the Company’s marketable debt securities at December 31, 2023:

 

    Amortized     Unrealized     Unrealized        
    Cost     Gain     (Loss)     Fair Value  
U.S. Treasury Bonds   $ 999     $     $ (3 )   $ 996  
U.S. Government Notes     8,191             (218 )     7,973  
Total marketable debt securities   $ 9,190     $     $ (221 )   $ 8,969